Hawthorne Effect Raises $20M in Series A Funding
- Hawthorne Effect, a San Francisco CA-based company which offers solutions for decentralizing clinical trials, raised $20M in Series A funding
- The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures
- The company intends to use the funds to accelerate growth and help scale operations
- The company’s tech-driven platform, the Hawthorne Cloud, works with highly trained medical professionals
- Since launching in 2015, the solution has been used across more than 50 clinical trials
- The company is actively engaged with more than 260 clinical sites and also runs trials as a single virtual site
